New derivatives of licochalcone A were synthesized and evaluated for their potential anticancer activities. Compounds 6 ((E)-N-(4-(3-(5-bromo-4-hydroxy-2-methoxy phenyl) acryloyl) phenyl)-4-isopropylbenzamide) and 8 (1-(3-dimethylamino-phenyl)-3-(2-trifluoromethyl-phenyl)-propenone) showed potent activity against the screened cancer cell lines with that of compound 6 ranging from 6.9 ± 0.2 μM to 22.9 ± 3.1 μM, and that of compound 8 from 4.2 ± 0.5 μM to 11.8 ± 0.7 μM. Both compounds showed stronger cytotoxicity than that of licochalcone A. These two candidates have very different substituents and could be considered as promising lead compounds for further development of potent anticancer agents.
KeshavaR., MuniyappaN., GopeR., RamaswamaiahA.S. (2016) Anti-cancer effects of Imperata cylindrica leaf extract on human oral squamous carcinoma cell line SCC-9 in vitro.Asian Pacific Journal of Cancer Prevention, 17, 1891–1898.
3.
KimK.H., YoonG., ChoJ.J., ChoJ.H., ChoY.S., ChaeJ.I., ShimJ.H. (2015) Licochalcone A induces apoptosis in malignant pleural mesothelioma through downregulation of Sp1 and subsequent activation of mitochondria-related apoptotic pathway. International Journal of Oncology, 46, 1385–1392.
4.
LiangX.H., LewisJ., FooteR., SmithD., KademaniD. (2008) Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. Journal of Oral and Maxillofacial Surgery, 66, 1875–1880.
5.
YoonG., KangB.Y., CheonS.H. (2007) Topoisomerase I inhibition and cytotoxicity of licochalcones A and E from Glycyrrhiza inflata. Archives of Pharmacal Research, 30, 313–316.
6.
ParkE.J., ParkH.R., LeeJ.S., KimJ. (1998) Licochalcone A: an inducer of cell differentiation and cytotoxic agent from Pogostemon cablin. Planta Medica, 64, 464–466.
KimJ.E., YoonG., ShimJ.H., ChoS.S. (2017) Broad spectrum antimicrobial activity of licochalcones A and E against MDR (multidrug resistant) strains of clinical origin. Natural product communications, 12, 1747–1748.
9.
KimJ.S., ParkM.R., LeeS.Y., KimD.K., MoonS.M., KimC.S., ChoS.S., YoonG., ImH.J., YouJ.S., OhJ.S., KimS.G. (2014) Licochalcone A induces apoptosis in KB human oral cancer cells via a caspase-dependent FasL signaling pathway. Oncology Reports, 31, 755–762.
10.
ChoJ.J., ChaeJ.I., YoonG., KimK.H., ChoJ.H., ChoS.S., ChoY.S., ShimJ.H. (2014) Licochalcone A, a natural chalconoid isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1 and Sp1 regulatory proteins in oral squamous cell carcinomaInternation Journal of Oncology, 45, 667–674.
11.
ParkM.R., KimS.G., ChoI.A., OhD., KangK.R., LeeS.Y., MoonS.M., ChoS.S., YoonG., KimC.S., OhJ.S., YouJ.S., KimD.K., SeoY.S., ImH.J., KimJ.S. (2015) Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells. Food and Chemical Toxicology, 77, 34–43.
12.
YoonG., LeeW., KimS.N., CheonS.H. (2009) Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B. Bioorganic & Medicinal Chemistry Letters, 19, 5155–5157.
13.
LiuZ., LeeW., KimS.N., YoonG., CheonS.H. (2011) Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors. Bioorganic & Medicinal Chemistry Letters, 21, 3755–3758.
14.
LessardL., StuibleM., TremblayM.L. (2010) The two faces of PTP1B in cancer. Biochimicaet Biophysica Acta, 1804, 613–619.
15.
JungY., CaoY., PaudelS., KimK.H., YoonG., CheonS.H., LeeJ-Y, KimS-N, KimY.K. (2016) A novel partial PPARα/γ dual agonist SN159 improves insulin sensitivity. Bulletin of the Korean Chemical Society, 37, 226–233.
16.
NielsenS.F., BoesenT., LarsenM., SchonningK., KromannH. (2004) Antibacterial chalcones–bioisosteric replacement of the 4′-hydroxy group. Bioorganic & Medicinal Chemistry, 12, 3047–3054.
